"uuid:ID","text","name","id","instanceType","description","label"
"c3dd9531-14d5-4b72-9a65-b9d888e0ef6c","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJ1","Objective_1","Objective","Main objective",""
"8b2e6f29-1f4b-43b1-a30b-e4667450f91d","To document the safety profile of the xanomeline TTS.","OBJ2","Objective_2","Objective","Safety",""
"92fb8930-2573-4169-a6ac-349369d1afa6","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJ3","Objective_3","Objective","Behaviour",""
